Ignite Creation Date:
2024-05-06 @ 4:05 PM
Last Modification Date:
2024-10-26 @ 2:03 PM
Study NCT ID:
NCT04867616
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2024-06-13
First Post:
2021-04-27
Brief Title:
A Study to Test the Efficacy Safety and Tolerability of Bepranemab UCB0107 in Patients With Mild Cognitive Impairment or Mild Alzheimers Disease AD
Sponsor:
UCB Biopharma SRL
Organization:
UCB Pharma